Would One Parkinson's Treatment Fit All?

This is an archived file of a live webcast that took place on April 21, 2016.

In this webinar we discuss how greater understanding of Parkinson's biology may lead to personalized therapies. Symptomatic and disease-modifying treatments could be prescribed based on genetic mutations or protein levels, much like is done in cancer care.

This event is part of the MJFF Third Thursdays Webinar series. Visit www.michaeljfox.org/webinars for more information and to view past webinars.

Title: Would One Parkinson's Treatment Fit All?

Duration: 1 hour

Continuing Medical Education Information for Health Care Professionals

Continuing Medical Education Information
MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

Date of Original Release: April 21, 2016
Date CME Credit No Longer Available: April 21, 2018

Learning Objectives
At the conclusion of this course, participants should be able to:

  • Describe what is meant by "personalized", or precision, medicine.
  • Summarize how Parkinson's disease (PD) patients are currently stratified into and within clinical trials for drug development.
  • Recognize how investigations into genetic mutations associated with Parkinson's (e.g., LRRK2, PARK2 and GBA) are potentially advancing understanding of the disease and therapeutic developments.
  • Identify ongoing efforts working toward personalized medicine for Parkinson's.

Target Audience
This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.

Nabila Dahodwala, MD
Assistant Professor of Neurology
University of Pennsylvania
No disclosures

Brian Fiske, PhD
Senior Vice President of Research Programs
The Michael J. Fox Foundation
No disclosures

Dave Iverson
No disclosures


Already Registered?

*Required Fields.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help.

By registering you agree to receive email updates from
The Michael J. Fox Foundation. You can unsubscribe any time.